Obermatt
See Similar Stocks →

Nuvalent

NSQ:NUVL · US6707031075
BiotechnologySmall

360° View

no current rank
Price/Sales32
Price/Earnings93
Price/Book20
Dividend Yield—
Revenue Growth—
Profit Growth4
Capital Growth57
TSR 52w28
Leverage28
Liquidity—
Refinancing59
Combined—
Analyst Opinions67
Pro Holdings71
Opinion Changes76
Market Pulse99

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2017
Employees230
Websitenuvalent.com
ISINUS6707031075
Last UpdateApr 2, 2026
Index & Theme
NeuroscienceOncologyNeurologyCentral Nervous SystemBiotechnologyLife ScienceTherapeutics

Description

Nuvalent, Inc. operates as a clinical-stage biopharmaceutical company. The company focuses on creating precisely targeted therapies for patients with cancer. The company leverages its team’s deep expertise in chemistry and structure-based drug desig…

Similar Stocks

The companies this stock is ranked against.

Compare Nuvalent with its peers
Black Diamond Therapeutics
NSQ:BDTX
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Oric Pharmaceuticals
NSQ:ORIC
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Verastem
NAQ:VSTM
56
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Celcuity
NAQ:CELC
96
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Olema Pharmaceuticals
NSQ:OLMA
28
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Day One Biopharmaceuticals
NSQ:DAWN
39
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →